title: Adalimumab for pediatric sympathetic ophthalmia.
authors.affiliation: Emory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
authors.forename: Joon-Bom
authors.initials: JB
authors.lastname: Kim
authors.affiliation: Emory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
authors.forename: Abdallah
authors.initials: A
authors.lastname: Jeroudi
authors.affiliation: Emory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia2Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia3Children's Hospital of Atlanta, Atlanta, Georgia.
authors.forename: Sheila T
authors.initials: ST
authors.lastname: Angeles-Han
authors.affiliation: Emory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
authors.forename: Hans E
authors.initials: HE
authors.lastname: Grossniklaus
authors.affiliation: Emory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
authors.forename: Steven
authors.initials: S
authors.lastname: Yeh
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009879:Ophthalmia, Sympathetic / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab